Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.

Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.

BACKGROUND: Fixed-dose combination scored dispersible stavudine, lamivudine, and nevirapine minitablets (Triomune Baby and Junior; Cipla Ltd) are simpler and cheaper than liquid formulations and have correct dose ratios for human immunodeficiency virus-infected children. However, they cannot be used...

Bibliográfalaš dieđut
Váldodahkkit:	Mulenga, V, Cook, A, Walker, A, Kabamba, D, Chijoka, C, Ferrier, A, Kalengo, C, Kityo, C, Kankasa, C, Burger, D, Thomason, M, Chintu, C, Gibb, D
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	2010

Geahča maid

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.
Dahkki: Fillekes, Q, et al.
Almmustuhtton: (2012)

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?
Dahkki: Fillekes, Q, et al.
Almmustuhtton: (2013)

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.
Dahkki: L'homme, R, et al.
Almmustuhtton: (2008)

Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.
Dahkki: Burger, D, et al.
Almmustuhtton: (2010)

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.
Dahkki: Oudijk, J, et al.
Almmustuhtton: (2012)

Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.
Dahkki: Ellis, J, et al.
Almmustuhtton: (2007)

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.
Dahkki: Gupta, R, et al.
Almmustuhtton: (2010)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects
Dahkki: Haberer, J, et al.
Almmustuhtton: (2011)

Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial.
Dahkki: Fillekes, Q, et al.
Almmustuhtton: (2013)

Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets
Dahkki: Bienczak, A, et al.
Almmustuhtton: (2017)

The effect of diurnal variation, CYP2B6 genotype, and age on the pharmacokinetics of nevirapine in African Children
Dahkki: Bienczak, A, et al.
Almmustuhtton: (2016)

The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.
Dahkki: Walker, A, et al.
Almmustuhtton: (2007)

Dynamics of accumulation of drug resistance mutations in the absence of virological monitoring in HIV-1-infected Zambian children using adult Triomune (fixed-dose combination d4T, 3TC and NVP)
Dahkki: Gupta, R, et al.
Almmustuhtton: (2009)

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
Dahkki: Prendergast, A, et al.
Almmustuhtton: (2011)

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.
Dahkki: Jessica E Haberer, et al.
Almmustuhtton: (2011-04-01)

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
Dahkki: Ryan, M, et al.
Almmustuhtton: (2008)

Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: A cohort study
Dahkki: Sinkala Moses, et al.
Almmustuhtton: (2008-12-01)

Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.
Dahkki: Walker, A, et al.
Almmustuhtton: (2009)

Intrapartum single-dose carbamazepine reduces nevirapine levels faster and may decrease resistance after a single dose of nevirapine for perinatal HIV prevention.
Dahkki: Muro, E, et al.
Almmustuhtton: (2012)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial.
Dahkki: Mulenga, V, et al.
Almmustuhtton: (2016)

Identification of the phenotypic, genotypic and fitness correlates of non-B subtype HIV-1 NRTI resistance through longitudinal analysis of children with virological failure in the developing world
Dahkki: Mbisa, J, et al.
Almmustuhtton: (2010)

Dynamics of emergence and linkage of HIV reverse transcriptase Q151M MDR complex in children within first-line antiretroviral rollout uncovered by single-genome sequencing
Dahkki: Mbisa, J, et al.
Almmustuhtton: (2009)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Dahkki: Munderi, P, et al.
Almmustuhtton: (2010)

Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir.
Dahkki: Ndembi, N, et al.
Almmustuhtton: (2010)

Examining gender differentials and determinants of private health insurance coverage in Zambia
Dahkki: James Mulenga, et al.
Almmustuhtton: (2021-11-01)

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.
Dahkki: Mbisa, J, et al.
Almmustuhtton: (2011)

Improved adherence to antiretroviral therapy observed among HIV-infected children whose caregivers had positive beliefs in medicine in Sub-Saharan Africa
Dahkki: Abongomera, G, et al.
Almmustuhtton: (2016)

'No sister, the breast alone is not enough for my baby' a qualitative assessment of potentials and barriers in the promotion of exclusive breastfeeding in southern Zambia
Dahkki: Kankasa Chipepo, et al.
Almmustuhtton: (2008-11-01)

Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP Trial.
Dahkki: Walker, A, et al.
Almmustuhtton: (2006)

Determinants of unmet need for family planning among married women in Zambia
Dahkki: James N. Mulenga, et al.
Almmustuhtton: (2020-04-01)

Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in Zambia.
Dahkki: Jeremy S Slone, et al.
Almmustuhtton: (2014-01-01)

Which pill should we take?
Dahkki: Shanthi Ameratunga

Which pill should we take?
Dahkki: Shanthi Ameratunga
Almmustuhtton: (2009-05-01)

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
Dahkki: Kikaire, B, et al.
Almmustuhtton: (2007)

Foetal loss and enhanced fertility observed in mice treated with Zidovudine or Nevirapine.
Dahkki: Chika K Onwuamah, et al.
Almmustuhtton: (2014-01-01)

Pharmacological and clinical evidence of nevirapine immediate- and extended-release formulations
Dahkki: Ena J, et al.
Almmustuhtton: (2012-11-01)

Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
Dahkki: Herzmann, C, et al.
Almmustuhtton: (2004)

The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African children
Dahkki: Bienczak, A, et al.
Almmustuhtton: (2016)

Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
Dahkki: Bienczak, A, et al.
Almmustuhtton: (2016)

Efavirenz challenge in patients with nevirapine induced Stevens-Johnson Syndrome
Dahkki: Thandekile C. Manzini, et al.
Almmustuhtton: (2016-12-01)